Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibitionRanjit K. Goudar, Jeremy N. Rich, Roger E. McLendon et al.|Molecular Cancer Therapeutics|2005Cited by 245
Loss of Phosphatase and Tensin Homologue Increases Transforming Growth Factor β–Mediated Invasion with Enhanced SMAD3 Transcriptional ActivityAnita B. Hjelmeland, Jeremy N. Rich, Mark D. Hjelmeland et al.|Cancer Research|2005Cited by 46